Glucose metabolic disorder in Klinefelter syndrome: a retrospective analysis in a single Chinese hospital and literature review

We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyp...

Full description

Saved in:
Bibliographic Details
Published inBMC endocrine disorders Vol. 21; no. 1; pp. 239 - 10
Main Authors Liu, Shixuan, Yuan, Tao, Song, Shuoning, Chen, Shi, Wang, Linjie, Fu, Yong, Dong, Yingyue, Tang, Yan, Zhao, Weigang
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 01.12.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.
AbstractList We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.
We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of [beta]-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.
Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. Results We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. Conclusions KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.
Background We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. Results We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of [beta]-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. Conclusions KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. Keywords: Klinefelter syndrome, Diabetes mellitus, Hyperglycemia, Insulin resistance, Hypoglycemic therapy
Abstract Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. Results We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. Conclusions KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.
We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.BACKGROUNDWe aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia.METHODSThis is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia.We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group.RESULTSWe found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group.KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.CONCLUSIONSKS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.
ArticleNumber 239
Audience Academic
Author Liu, Shixuan
Song, Shuoning
Yuan, Tao
Wang, Linjie
Chen, Shi
Dong, Yingyue
Zhao, Weigang
Tang, Yan
Fu, Yong
Author_xml – sequence: 1
  givenname: Shixuan
  surname: Liu
  fullname: Liu, Shixuan
– sequence: 2
  givenname: Tao
  surname: Yuan
  fullname: Yuan, Tao
– sequence: 3
  givenname: Shuoning
  surname: Song
  fullname: Song, Shuoning
– sequence: 4
  givenname: Shi
  surname: Chen
  fullname: Chen, Shi
– sequence: 5
  givenname: Linjie
  surname: Wang
  fullname: Wang, Linjie
– sequence: 6
  givenname: Yong
  surname: Fu
  fullname: Fu, Yong
– sequence: 7
  givenname: Yingyue
  surname: Dong
  fullname: Dong, Yingyue
– sequence: 8
  givenname: Yan
  surname: Tang
  fullname: Tang, Yan
– sequence: 9
  givenname: Weigang
  surname: Zhao
  fullname: Zhao, Weigang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34852815$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9v1DAQxSNURP_AF-CAInHhkmI7seNwQKpWbamoxKV3y7Enu1458WIni_bEV2fSLdVuhVAOice_95wZv_PsZAgDZNl7Si4pleJzoqwhrCCMFoTIpiz4q-yMVjUrhGTlycH3aXae0poQWktG3mSnZSU5k5SfZb9v_WRCgryHUbfBO5Nbl0K0EHM35N-9G6ADP-Iy7QYbQw9fcp1HGGNIGzCj20KuB-13yaVZofPkhqWHfLFCKRqvkHOj9kjZ3Dt00uMUAS22Dn69zV532id49_S-yB5urh8W34r7H7d3i6v7wnBRjoWFCoBbY7RmlWxr3pZVLbQsrSQ1qSgzpu6ga7URsmkoE4Jq02loJTfc0vIiu9vb2qDXahNdr-NOBe3UYyHEpdJxdMaDogyg5QJKAlDx1rQ1KXGETVljuasIen3de22mtgdrYBij9kemxzuDW6ll2Cop0IjNP_PpySCGnxOkUfUuGfBeDxCmpJggXBCCnSD68QW6DlPEcc8UpSXecHVALTU24IYu4LlmNlVXAk9tGBccqct_UPhY6J3BaHUO60eCD4eNPnf4Nz0IsD1gMAwpQveMUKLmiKp9RBVGVD1GVM0i-UJkMB6jC_OwnP-f9A9djOxY
CitedBy_id crossref_primary_10_2147_DMSO_S498230
crossref_primary_10_3390_nu14102107
crossref_primary_10_3390_biom13121759
crossref_primary_10_1016_j_beem_2022_101654
Cites_doi 10.1111/jdi.13113
10.2337/dc06-0651
10.1111/j.1743-6109.2010.01991.x
10.2337/diacare.22.9.1462
10.1007/s40618-017-0619-9
10.1161/01.CIR.0000111245.75752.C6
10.2169/internalmedicine.31.917
10.1111/j.1651-2227.2011.02233.x
10.1210/jc.2014-2780
10.1111/cen.12664
10.1210/jc.2005-1077
10.1007/s12020-015-0613-y
10.2169/internalmedicine.35.396
10.1530/eje.1.02166
10.1385/ENDO:27:1:011
10.1210/er.2017-00212
10.1097/MED.0000000000000154
10.1016/j.fertnstert.2012.07.1122
10.1507/endocrj.49.523
10.1210/jc.2012-2382
10.1007/s12020-018-1584-6
10.1210/jc.2005-0697
10.1111/j.1651-2227.2011.02161.x
10.1056/NEJMoa0911101
10.1677/joe.0.0350169
10.1210/jcem.85.7.6661
10.2337/dc13-2845
10.2169/internalmedicine.41.842
10.1111/andr.12275
10.1111/bju.12037
10.1097/MD.0000000000017342
10.2169/internalmedicine.48.1985
10.1530/EC-18-0031
10.1016/j.metabol.2017.09.017
10.1016/j.urology.2008.01.051
10.3803/EnM.2016.31.4.598
10.1155/2019/9616125
10.1001/archinte.1966.00290160014004
10.1016/j.diabet.2011.01.002
10.1210/jcem-29-8-1062
10.1159/000090327
10.1001/jama.2015.10029
10.2337/dc19-S002
10.2337/dc10-2339
10.1007/BF00280883
10.1016/j.ijcard.2012.09.215
10.1210/jc.2016-2904
10.1007/s11892-019-1197-3
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12902-021-00893-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Publicly Available Content Database


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1472-6823
EndPage 10
ExternalDocumentID oai_doaj_org_article_12eeb56e30ee45bcb703823937eb5f40
PMC8638221
A686392565
34852815
10_1186_s12902_021_00893_5
Genre Journal Article
Review
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QP
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-de4ee5dccaa248b75b3476a83d8070412cc7fefbac689912661acfaeb85c5d13
IEDL.DBID 7X7
ISSN 1472-6823
IngestDate Wed Aug 27 01:29:57 EDT 2025
Thu Aug 21 18:42:38 EDT 2025
Thu Jul 10 19:13:29 EDT 2025
Fri Jul 25 06:22:46 EDT 2025
Tue Jun 17 21:51:20 EDT 2025
Tue Jun 10 20:24:44 EDT 2025
Thu Jan 02 22:55:48 EST 2025
Tue Jul 01 01:37:14 EDT 2025
Thu Apr 24 22:52:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Klinefelter syndrome
Insulin resistance
Hyperglycemia
Hypoglycemic therapy
Diabetes mellitus
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-de4ee5dccaa248b75b3476a83d8070412cc7fefbac689912661acfaeb85c5d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/2611314749?pq-origsite=%requestingapplication%
PMID 34852815
PQID 2611314749
PQPubID 44656
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_12eeb56e30ee45bcb703823937eb5f40
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8638221
proquest_miscellaneous_2605600689
proquest_journals_2611314749
gale_infotracmisc_A686392565
gale_infotracacademiconefile_A686392565
pubmed_primary_34852815
crossref_primary_10_1186_s12902_021_00893_5
crossref_citationtrail_10_1186_s12902_021_00893_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC endocrine disorders
PublicationTitleAlternate BMC Endocr Disord
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References MZ Bardsley (893_CR29) 2011; 100
A Menke (893_CR40) 2015; 314
SJ Han (893_CR20) 2016; 31
D Kapoor (893_CR49) 2006; 154
D Pasquali (893_CR26) 2013; 168
M Gotoh (893_CR33) 2002; 49
G Corona (893_CR44) 2011; 8
A Bojesen (893_CR11) 2006; 91
B Antuna-Puente (893_CR18) 2011; 37
D Pei (893_CR47) 1998; 97
KA Groth (893_CR53) 2013; 98
HJ Kim (893_CR35) 2006; 65
C Wang (893_CR43) 2011; 34
M Matsuda (893_CR17) 1999; 22
FC Wu (893_CR42) 2010; 363
M Grossmann (893_CR52) 2015; 83
AS Herlihy (893_CR3) 2015; 22
M Jiang-Feng (893_CR6) 2012; 98
K Isobe (893_CR37) 1992; 31
K Tojo (893_CR38) 1996; 35
S Hara (893_CR31) 1970; 62
KW Lee (893_CR48) 1998; 13
EJ Gianatti (893_CR51) 2014; 37
L Wei (893_CR30) 2019; 98
893_CR36
KL Becker (893_CR25) 1966; 118
893_CR34
J Nielsen (893_CR9) 1969; 29
DR Matthews (893_CR19) 1985; 28
MJ O'Connor (893_CR2) 2019; 19
AE Calogero (893_CR7) 2017; 40
IM Jackson (893_CR24) 1966; 35
K Ota (893_CR23) 2002; 41
SM Davis (893_CR28) 2017; 102
A Katz (893_CR16) 2000; 85
CH Gravholt (893_CR5) 2011; 100
SM Grundy (893_CR15) 2004; 109
J Mirouze (893_CR41) 1966; 14
WS Tan (893_CR50) 2013; 111
F Panimolle (893_CR46) 2016; 52
Z Yesilova (893_CR21) 2005; 27
S Davis (893_CR27) 2016; 4
M Zitzmann (893_CR45) 2015; 100
AJ Swerdlow (893_CR12) 2005; 90
H Falhammar (893_CR22) 2018; 7
I Yoshiuchi (893_CR32) 2006; 29
M Ayli (893_CR39) 2009; 48
T Ishikawa (893_CR4) 2008; 71
893_CR13
893_CR14
GA Kanakis (893_CR1) 2018; 86
CH Gravholt (893_CR8) 2018; 39
893_CR10
References_xml – ident: 893_CR36
  doi: 10.1111/jdi.13113
– volume: 29
  start-page: 1981
  issue: 8
  year: 2006
  ident: 893_CR32
  publication-title: Diabetes Care
  doi: 10.2337/dc06-0651
– volume: 14
  start-page: 57
  issue: 2
  year: 1966
  ident: 893_CR41
  publication-title: Diabete
– volume: 8
  start-page: 272
  issue: 1
  year: 2011
  ident: 893_CR44
  publication-title: J Sex Med
  doi: 10.1111/j.1743-6109.2010.01991.x
– volume: 22
  start-page: 1462
  issue: 9
  year: 1999
  ident: 893_CR17
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.9.1462
– volume: 40
  start-page: 705
  issue: 7
  year: 2017
  ident: 893_CR7
  publication-title: J Endocrinol Investig
  doi: 10.1007/s40618-017-0619-9
– volume: 109
  start-page: 433
  issue: 3
  year: 2004
  ident: 893_CR15
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000111245.75752.C6
– volume: 31
  start-page: 917
  issue: 7
  year: 1992
  ident: 893_CR37
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.31.917
– volume: 100
  start-page: 871
  issue: 6
  year: 2011
  ident: 893_CR5
  publication-title: Acta Paediatr
  doi: 10.1111/j.1651-2227.2011.02233.x
– volume: 100
  start-page: E518
  issue: 3
  year: 2015
  ident: 893_CR45
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-2780
– volume: 83
  start-page: 344
  issue: 3
  year: 2015
  ident: 893_CR52
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/cen.12664
– volume: 90
  start-page: 6516
  issue: 12
  year: 2005
  ident: 893_CR12
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1077
– volume: 52
  start-page: 157
  issue: 1
  year: 2016
  ident: 893_CR46
  publication-title: Endocrine
  doi: 10.1007/s12020-015-0613-y
– volume: 35
  start-page: 396
  issue: 5
  year: 1996
  ident: 893_CR38
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.35.396
– volume: 154
  start-page: 899
  issue: 6
  year: 2006
  ident: 893_CR49
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.1.02166
– volume: 27
  start-page: 11
  issue: 1
  year: 2005
  ident: 893_CR21
  publication-title: Endocrine
  doi: 10.1385/ENDO:27:1:011
– volume: 39
  start-page: 389
  issue: 4
  year: 2018
  ident: 893_CR8
  publication-title: Endocr Rev
  doi: 10.1210/er.2017-00212
– volume: 22
  start-page: 224
  issue: 3
  year: 2015
  ident: 893_CR3
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0000000000000154
– volume: 98
  start-page: 1331
  issue: 5
  year: 2012
  ident: 893_CR6
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2012.07.1122
– volume: 49
  start-page: 523
  issue: 4
  year: 2002
  ident: 893_CR33
  publication-title: Endocr J
  doi: 10.1507/endocrj.49.523
– volume: 98
  start-page: 20
  issue: 1
  year: 2013
  ident: 893_CR53
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-2382
– ident: 893_CR10
  doi: 10.1007/s12020-018-1584-6
– volume: 97
  start-page: 534
  issue: 8
  year: 1998
  ident: 893_CR47
  publication-title: J Formos Med Assoc
– volume: 91
  start-page: 1254
  issue: 4
  year: 2006
  ident: 893_CR11
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0697
– volume: 100
  start-page: 866
  issue: 6
  year: 2011
  ident: 893_CR29
  publication-title: Acta Paediatr
  doi: 10.1111/j.1651-2227.2011.02161.x
– volume: 363
  start-page: 123
  issue: 2
  year: 2010
  ident: 893_CR42
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0911101
– volume: 35
  start-page: 169
  issue: 2
  year: 1966
  ident: 893_CR24
  publication-title: J Endocrinol
  doi: 10.1677/joe.0.0350169
– volume: 85
  start-page: 2402
  issue: 7
  year: 2000
  ident: 893_CR16
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.85.7.6661
– volume: 37
  start-page: 2098
  issue: 8
  year: 2014
  ident: 893_CR51
  publication-title: Diabetes Care
  doi: 10.2337/dc13-2845
– volume: 41
  start-page: 842
  issue: 10
  year: 2002
  ident: 893_CR23
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.41.842
– volume: 4
  start-page: 1169
  issue: 6
  year: 2016
  ident: 893_CR27
  publication-title: Andrology
  doi: 10.1111/andr.12275
– volume: 111
  start-page: 1130
  issue: 7
  year: 2013
  ident: 893_CR50
  publication-title: BJU Int
  doi: 10.1111/bju.12037
– volume: 98
  start-page: e17342
  issue: 39
  year: 2019
  ident: 893_CR30
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000017342
– volume: 48
  start-page: 1681
  issue: 18
  year: 2009
  ident: 893_CR39
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.48.1985
– volume: 7
  start-page: 466
  issue: 3
  year: 2018
  ident: 893_CR22
  publication-title: Endocr Connect
  doi: 10.1530/EC-18-0031
– volume: 86
  start-page: 135
  year: 2018
  ident: 893_CR1
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2017.09.017
– volume: 71
  start-page: 1109
  issue: 6
  year: 2008
  ident: 893_CR4
  publication-title: Urology
  doi: 10.1016/j.urology.2008.01.051
– volume: 31
  start-page: 598
  issue: 4
  year: 2016
  ident: 893_CR20
  publication-title: Endocrinol Metab (Seoul)
  doi: 10.3803/EnM.2016.31.4.598
– ident: 893_CR34
  doi: 10.1155/2019/9616125
– volume: 118
  start-page: 314
  issue: 4
  year: 1966
  ident: 893_CR25
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1966.00290160014004
– volume: 13
  start-page: 495
  year: 1998
  ident: 893_CR48
  publication-title: J Korean Soc Endocrinol
– volume: 37
  start-page: 179
  issue: 3
  year: 2011
  ident: 893_CR18
  publication-title: Diabetes Metab
  doi: 10.1016/j.diabet.2011.01.002
– volume: 29
  start-page: 1062
  issue: 8
  year: 1969
  ident: 893_CR9
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-29-8-1062
– volume: 65
  start-page: 14
  issue: 1
  year: 2006
  ident: 893_CR35
  publication-title: Horm Res
  doi: 10.1159/000090327
– volume: 314
  start-page: 1021
  issue: 10
  year: 2015
  ident: 893_CR40
  publication-title: Jama
  doi: 10.1001/jama.2015.10029
– ident: 893_CR13
  doi: 10.2337/dc19-S002
– volume: 34
  start-page: 1669
  issue: 7
  year: 2011
  ident: 893_CR43
  publication-title: Diabetes Care
  doi: 10.2337/dc10-2339
– volume: 28
  start-page: 412
  issue: 7
  year: 1985
  ident: 893_CR19
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 168
  start-page: 754
  issue: 2
  year: 2013
  ident: 893_CR26
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2012.09.215
– volume: 102
  start-page: 176
  issue: 1
  year: 2017
  ident: 893_CR28
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-2904
– volume: 62
  start-page: 42
  issue: 1
  year: 1970
  ident: 893_CR31
  publication-title: J Natl Med Assoc
– ident: 893_CR14
– volume: 19
  start-page: 71
  issue: 9
  year: 2019
  ident: 893_CR2
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-019-1197-3
SSID ssj0017820
Score 2.2625542
SecondaryResourceType review_article
Snippet We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a...
Background We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia....
We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a...
Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods...
We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.BACKGROUNDWe aimed...
Abstract Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 239
SubjectTerms Adolescent
Analysis
Beta cells
Blood glucose
Blood pressure
Blood sugar
Body mass index
Child
China - epidemiology
Diabetes
Diabetes mellitus
Diabetes Mellitus - epidemiology
Dyslipidemia
Dyslipidemias - epidemiology
Electronic medical records
Glucose
Glucose metabolism
Glucose Metabolism Disorders - epidemiology
Glucose tolerance
Glucose tolerance tests
Health aspects
Homeostasis
Hospitals
Humans
Hyperglycemia
Hyperglycemia - epidemiology
Hypertension
Hypertension - epidemiology
Hypoglycemia
Hypoglycemic therapy
Insulin
Insulin Resistance
Insulin secretion
Insulin-Secreting Cells - physiology
Klinefelter syndrome
Klinefelter Syndrome - epidemiology
Klinefelter Syndrome - physiopathology
Klinefelter's syndrome
Laboratories
Literature reviews
Male
Medical records
Medical research
Medicine, Experimental
Metabolic disorders
Metabolic syndrome
Pancreatic beta cells
Patients
Population
Prediabetic state
Prediabetic State - epidemiology
Retrospective Studies
Secretion
Values
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na90wDDejh7LL2PeydcWDwQ7D9Dm2E7_e2rKubHSnDnoz_lDog7e88pqe969XSpzwwmC77BrLiW3JlhRLPzH2Eco6aaVqUdugBepbLbxXUoQmxWYZF41eUoLz5Y_q4qf-dm2ud0p9UUzYAA88LNyRLAGCqUAtALQJMaCIWsLtqvFxo3tvHXXe6Ezl-wNCgRtTZGx1dEd_W0pB4Qio85ZKmJka6tH6_zyTd5TSPGByRwOdP2VPsunIT4YhP2OPoH3O9i_z5fgL9vvrEH7Of0GHrF2vIk8ZW5OvWv6dDMoG6HacjzgFx9zzLXTbzZhwyX0GKaEentOPhDVwKrIN-OKbXGQEqRJfT4DMfMh_ecmuzr9cnV2IXF9BRFOpTiTQACYhD32pbahNULquvFXJ4kGgZRlj3UATfKzQK5Okyn1sPARroklSvWJ77aaFN4wrWQWJTXIRGu1NCBrtiqQ8oHOEFmIomBxX28WMPU4lMNau90Fs5QYOOeSQ6znkTME-T31uB-SNv1KfEhMnSkLN7h-gLLksS-5fslSwTyQCjvY2Di_6nKKAkySULHdSWTTo0EjEzx3MKHFPxnnzKEQunwl3Dn1VqaSu9bJgH6Zm6klxbi1s7olmQSYornfBXg8yN01JaWtKK_Hl9UwaZ3Oet7Srmx4xHMeFhqB8-z8W6R17XNJG6kN6Dthet72H92iYdeGw34MPZeU3Dg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9cwEA9zgvgi_rZzSgTBB6l-0yRtvoLIFOdQvj5tsLeQpNftC7Vf13WgT_7r3rVpXXHstUnaJHeXu2vuPsfYS8iKUklZpIXxKkV9q1LnpEh9VYZqGRaVWlKC8-p7fnCkvh7r4y02ljuKG3h-pWtH9aSO2vrNr7PfH1Dg3_cCb_K35_QvJUsp2AA12lKm-ga7iZqpIEFdqX-3CoQNNybOXDluppx6DP__T-pLqmoeRnlJL-3fZXeiQcn3Bg64x7aguc9ureKV-QP258sQlM5_QIcEr9eBlxFxk68b_o3MzArozpyP6AXvuOMtdO1mTMPkLkKX0AjH6fdCDZxKbwO--DSWHsFeJa8nmGY-ZMU8ZIf7nw8_HaSx6kIadC67tAQFoEukrMuU8YX2UhW5M7I0eDwokYVQVFB5F3L01QQpeBcqB97ooEshH7HtZtPAE8alyL3AJrHwlXLae4XWRikdoMuEdqNPmBh324aISE6FMWrbeyYmtwOFLFLI9hSyOmGvpzE_BzyOa3t_JCJOPQlLu3-waU9sFE0rMgCvc5ALAKV98HgIGkKGK_BxpRYJe0UsYIkHcXrBxcQFXCRhZ9m93KCZh6Yjfm531hMlNcybRyayI6Nb9GCFFKpQy4S9mJppJEW_NbC5oD4LMkxxvxP2eOC5aUlSGZ0ZgS8vZtw4W_O8pVmf9jjiOC80D8XO9dN6ym5nJCJ9CM8u2-7aC3iGhljnn_fS9Rcp7jGl
  priority: 102
  providerName: Scholars Portal
Title Glucose metabolic disorder in Klinefelter syndrome: a retrospective analysis in a single Chinese hospital and literature review
URI https://www.ncbi.nlm.nih.gov/pubmed/34852815
https://www.proquest.com/docview/2611314749
https://www.proquest.com/docview/2605600689
https://pubmed.ncbi.nlm.nih.gov/PMC8638221
https://doaj.org/article/12eeb56e30ee45bcb703823937eb5f40
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96B-KL-O3quUQQfJByTZO0WV_kVu48lD3kOGHxJSTp1FtY23N379l_3Zk2rVeEe-lDk7RJZjIzSWZ-w9hbyIpSSVkkhfEqQX2rEuekSHxVhmoW0krNKMB5cZaffldflnoZD9y20a2yl4mtoC6bQGfkh2jpCylUoWYfr34nlDWKbldjCo27bJ-gy8ilq1gOGy5BWHB9oIzJD7d05pIl5JSAmm8mEz1SRi1m__-S-YZqGrtN3tBDJw_Zg2hA8qOO4o_YHagfs3uLeEX-hP353Dmh81-wQwKvV4GXEWGTr2r-lczKCuiOnPdoBR-44xvYbZo-7JK7CFVCLRyn44Q1cEq1Dfjhy5hqBGuVfD3AMvMuCuYpuzg5vvh0msQsC0nQudwlJSgAXSIlXaaML7SXqsidkaVBcaBEFkJRQeVdyHFvJkihu1A58EYHXQr5jO3VTQ0vGJci9wKLROor5bT3Cq2LUjrALRLaiX7CRD_bNkQEckqEsbbtTsTktqOQRQrZlkJWT9j7oc1Vh79xa-05EXGoSdjZ7Ytm89PGpWhFBuB1DjIFUNoHj0LPEBJcga8rlU7YO2IBSyscuxdcDFTAQRJWlj3KDZp1aCri7w5GNXFlhnFxz0Q2Soat_cfHE_ZmKKaW5O1WQ3NNdVIyRHG-J-x5x3PDkKQyOjMCP16MuHE05nFJvbpsccOxX2gOipe3d-sVu5_REmlddg7Y3m5zDa_R8Nr5abu6pmx_fnz27XzaHl_gc6EMPs_nP_4CpCoy9Q
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKgEXxLMEChgJxAGtGq_tXQcJoRZaUtJECBWpN8v2ztJIYVOSVIgTv4j_yMy-6Aqpt17Xj7U945mxPfMNYy8gTjMlZRqlxqsI9a2KnJMi8nkW8mEY5GpIAc6TaTL6qj6d6JMN9qeJhSG3ykYmloI6WwS6I99BS19IoVI1fHf2I6KsUfS62qTQqNhiDL9-4pFt9fbwA9L3ZRwf7B-_H0V1VoEo6ESuowwUgM5w5C5WxqfaS5UmzsjMIPsrEYeQ5pB7FxI8iwhSYC7kDrzRQWdCYrfX2KaSeJLpsc29_ennL-2zBYHPNZE5JtlZ0SVPHJEXBKraoYx0R_uVSQL-VwUXdGHXT_OC4ju4zW7VFivfrVjsDtuA4i67Pqnf5O-x3x8rr3f-HdbIUfNZ4FkN6clnBR-THZsDPcrzBh7hDXd8Cevloonz5K7GRqEWjtP9xRw45fYG7Pi0zm2CtTI-b3GgeRV2c58dXwUBHrBesSjgIeNSJF5gkRj4XDntvUJzJpMO8EyGhqnvM9Gstg015Dll3pjb8uhjEltRyCKFbEkhq_vsddvmrAL8uLT2HhGxrUlg3eWHxfKbrfe-FTGA1wnIAYDSPniUsoag51L8nKtBn70iFrAkUnB4wdWREThJAueyu4lBOxJtU_zddqcmioLQLW6YyNaiaGX_bZw-e94WU0tyrytgcU51BmT54nr32VbFc-2UpDI6NgI7Tzvc2Jlzt6SYnZZA5TgutD_Fo8uH9YzdGB1PjuzR4XT8mN2MabuU_kLbrLdensMTtPrW_mm91zizV7y7_wKi3W36
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glucose+metabolic+disorder+in+Klinefelter+syndrome%3A+a+retrospective+analysis+in+a+single+Chinese+hospital+and+literature+review&rft.jtitle=BMC+endocrine+disorders&rft.au=Liu%2C+Shixuan&rft.au=Yuan%2C+Tao&rft.au=Song%2C+Shuoning&rft.au=Chen%2C+Shi&rft.date=2021-12-01&rft.pub=BioMed+Central&rft.eissn=1472-6823&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12902-021-00893-5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6823&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6823&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6823&client=summon